Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy R Cook

Showing results (241-250 of 368) with videos related to

Pageof 37
Sort By:
JACC. Clinical Electrophysiology|August 1, 2021
Diabetes and Risk of Sudden Death in Coronary Artery Disease Patients Without Severe Systolic DysfunctionRamkumar V Venkateswaran, M V Moorthy, Neal A Chatterjee, et al.
Lancet (London, England)|July 19, 2018
Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trialsPeter M Rothwell, Nancy R Cook, J Michael Gaziano, et al.
Clinical Chemistry|March 15, 2011
Circulating inflammatory and endothelial markers and risk of hypertension in white and black postmenopausal womenLu Wang, Joann E Manson, J Michael Gaziano, et al.
Metabolism: Clinical and Experimental|February 6, 2008
Dietary glycemic index, dietary glycemic load, blood lipids, and C-reactive proteinEmily B Levitan, Nancy R Cook, Meir J Stampfer, et al.
BMJ (Clinical Research Ed.)|April 24, 2007
Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)Nancy R Cook, Jeffrey A Cutler, Eva Obarzanek, et al.
JAMA Cardiology|January 7, 2026
Thirty-Year Risk of Cardiovascular Disease Among Healthy Women According to Clinical Thresholds of Lipoprotein(a)Ask Tybjærg Nordestgaard, Daniel I Chasman, Vinayaga Moorthy, et al.
Contemporary Clinical Trials|March 13, 2018
The VITamin D and OmegA-3 TriaL-Depression Endpoint Prevention (VITAL-DEP): Rationale and design of a large-scale ancillary study evaluating vitamin D and marine omega-3 fatty acid supplements for prevention of late-life depressionOlivia I Okereke, Charles F Reynolds, David Mischoulon, et al.
Archives of Internal Medicine|January 14, 2009
Joint effects of sodium and potassium intake on subsequent cardiovascular disease: the Trials of Hypertension Prevention follow-up studyNancy R Cook, Eva Obarzanek, Jeffrey A Cutler, et al.
Journal of the American College of Cardiology|May 22, 2010
The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women's health study)Usha B Tedrow, David Conen, Paul M Ridker, et al.
Archives of Internal Medicine|December 13, 2006
C-reactive protein in the prediction of rheumatoid arthritis in womenNancy A Shadick, Nancy R Cook, Elizabeth W Karlson, et al.
Pageof 37

Showing results (241-250 of 368) with videos related to

Sort By:
Pageof 37
JACC. Clinical Electrophysiology|August 1, 2021
Diabetes and Risk of Sudden Death in Coronary Artery Disease Patients Without Severe Systolic DysfunctionRamkumar V Venkateswaran, M V Moorthy, Neal A Chatterjee, et al.
Lancet (London, England)|July 19, 2018
Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trialsPeter M Rothwell, Nancy R Cook, J Michael Gaziano, et al.
Clinical Chemistry|March 15, 2011
Circulating inflammatory and endothelial markers and risk of hypertension in white and black postmenopausal womenLu Wang, Joann E Manson, J Michael Gaziano, et al.
Metabolism: Clinical and Experimental|February 6, 2008
Dietary glycemic index, dietary glycemic load, blood lipids, and C-reactive proteinEmily B Levitan, Nancy R Cook, Meir J Stampfer, et al.
BMJ (Clinical Research Ed.)|April 24, 2007
Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP)Nancy R Cook, Jeffrey A Cutler, Eva Obarzanek, et al.
JAMA Cardiology|January 7, 2026
Thirty-Year Risk of Cardiovascular Disease Among Healthy Women According to Clinical Thresholds of Lipoprotein(a)Ask Tybjærg Nordestgaard, Daniel I Chasman, Vinayaga Moorthy, et al.
Contemporary Clinical Trials|March 13, 2018
The VITamin D and OmegA-3 TriaL-Depression Endpoint Prevention (VITAL-DEP): Rationale and design of a large-scale ancillary study evaluating vitamin D and marine omega-3 fatty acid supplements for prevention of late-life depressionOlivia I Okereke, Charles F Reynolds, David Mischoulon, et al.
Archives of Internal Medicine|January 14, 2009
Joint effects of sodium and potassium intake on subsequent cardiovascular disease: the Trials of Hypertension Prevention follow-up studyNancy R Cook, Eva Obarzanek, Jeffrey A Cutler, et al.
Journal of the American College of Cardiology|May 22, 2010
The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women's health study)Usha B Tedrow, David Conen, Paul M Ridker, et al.
Archives of Internal Medicine|December 13, 2006
C-reactive protein in the prediction of rheumatoid arthritis in womenNancy A Shadick, Nancy R Cook, Elizabeth W Karlson, et al.
Pageof 37